NASDAQ$ASRT

Assertio Holdings Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Assertio's third quarter results reflected stable performance, driven by Rolvedon and economic returns from the commercial portfolio.

Assertio Holdings reported solid performance in Q3 2024, with Rolvedon establishing itself as the lead asset, contributing to a total net product sales of $28.7 million. The company is implementing new strategies for Sympazan and maximizing the value of Indocin while evaluating new growth opportunities.

  • Rolvedon net product sales were stable at $15.0 million.
  • Indocin net product sales decreased to $5.7 million due to generic competition.
  • Gross margin increased to 74% due to a decrease in inventory write-downs and completion of Rolvedon inventory step-up amortization.
  • Cash, cash equivalents and short-term investments were $88.6 million.

Headline financials

Total Revenue

$29.2M

Previous: $35.6M-18.0%
EPS

-$0.03

Previous: $0.01-400.0%
SG&A Expenses

$16.7M

No prior period
Adjusted EBITDA

$4.42M

No prior period
Gross Margin

74.0%

Previous: 80.0%-7.5%
Capital Expenditures

$0.00

Previous: -$528K+100.0%
Free Cash Flow

-$2.92M

Previous: -$280M+99.0%
Net Income

-$2.92M

Previous: -$280M+99.0%
Operating Income

-$3.05M

Previous: -$228M+98.7%
Gross Profit

-$7.55M

Previous: -$7.06M-6.9%
Cash & Equivalents

$38M

Previous: $76.9M-50.6%
Total Assets

$276M

Previous: $380M-27.4%
R&D Expense

$1.01M

Previous: $1.32M-23.6%
Stock-Based Comp

$1.3M

Previous: $1.87M-30.5%

Revenue & EPS history

Assertio · Revenue · Quarterly

$29.2M

Q3 2024-18%vs Q3 2023
Beat estimate in 11 of 14 quarters(79%)
ActualEstimate

Revenue by segment

Assertio · $40.1M total across 1 segment · Q2 2023

  • Net Product Sales
    $40.1M

Forward guidance

Assertio did not provide specific forward guidance in this earnings report.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-1.9%

Avg return

Earnings day

-4.4%

Avg return

5 days after

-4.5%

Avg return

30 days after

52%

33 / 64 earnings

Positive

+33.3%

Q3 2021

Best reaction

-46.2%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+4.2%+4.7%
Q4 2025+6.5%+13.6%+53.1%
Q3 2025+13.3%-1.2%-1.2%
Q1 2025-1.8%+8.1%+0.0%
Q4 2024-7.5%-7.7%-20.5%
Q3 2024+0.2%-4.7%+12.9%
Q2 2024-12.8%-14.4%+0.8%
Q1 2024+7.8%-6.8%-2.9%
Q4 2023+10.8%+23.1%-1.1%
Q3 2023-45.5%-53.2%-50.9%
Q2 2023-46.2%-41.0%-39.0%
Q1 2023+20.6%+22.2%-3.8%
Q4 2022+7.9%-15.1%-0.6%
Q3 2022-0.4%+10.4%+38.1%
Q2 2022-4.3%-4.8%-32.6%
Q1 2022+6.2%+37.5%+52.9%
Q4 2021+13.8%-0.5%+56.9%
Q3 2021+33.3%+36.0%+18.4%
Q2 2021-2.3%-3.1%-16.3%
Q1 2021+11.8%-3.9%-11.8%
Q4 2020+4.3%-3.2%-35.1%
Q3 2020-41.8%-40.3%-37.3%
Q2 2020-13.8%-18.1%-23.4%
Q1 2020+1.3%+1.2%+21.3%
Q4 2019-35.1%-29.8%-37.7%
Q3 2019-9.6%-13.3%-14.5%
Q2 2019+1.4%-45.1%-54.2%
Q1 2019-0.4%-10.8%-37.9%
Q4 2018-5.8%-12.7%+26.8%
Q3 2018+6.5%+5.5%-16.3%
Q2 2018-19.0%-23.0%-33.5%
Q1 2018+26.5%+23.5%+10.6%
Q4 2017-11.4%-12.3%-15.0%
Q3 2017+15.4%+30.0%+68.6%
Q2 2017-35.1%-33.3%-37.4%
Q1 2017+2.3%+9.0%-3.1%
Q4 2016+4.7%-0.9%-9.9%
Q3 2016-16.1%-8.0%-12.1%
Q2 2016+5.6%+10.2%+8.7%
Q1 2016-6.2%
Q4 2015-4.1%
Q3 2015+6.7%
Q2 2015-7.2%
Q1 2015-14.1%
Q4 2014+13.4%
Q3 2014-2.7%
Q2 2014+5.5%
Q1 2014-23.5%
Q4 2013+14.8%
Q3 2013-0.5%
Q2 2013+4.0%
Q1 2013-2.8%
Q4 2012+6.2%
Q3 2012+1.5%
Q2 2012-0.5%
Q1 2012+3.2%
Q4 2011+3.3%
Q3 2011-10.4%
Q2 2011+3.1%
Q1 2011-1.2%
Q4 2010+0.6%
Q3 2010-0.2%
Q2 2010+5.2%
Q1 2010-4.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro